Patents
US 8119163 B2: Nanoparticulate and controlled release compositions comprising cefditoren
- Granted
- 2012-02-21
- Filed
- 2007-02-05 application 11671276
- Type
- Utility · 22 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
The present invention provides a composition comprising a cefditoren, or a salt, derivative, prodrug, or other form thereof, for example, cefditoren pivoxil, useful in the treatment and prevention of infections and related conditions. The invention provides a composition which comprises nanoparticulate particles comprising the cefditoren, or a salt, derivative, prodrug, or other form thereof and at least one surface stabilizer. The nanoparticulate particles have an effective average particle size of less than about 2000 nm. The invention provides also a composition that delivers a cefditoren, or a salt, derivative, prodrug, or other form thereof, or nanoparticles comprising the same, in a pulsatile or continuous manner.
Source: PVGPATDIS, file of 2026-04-10 (ipg120221.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| Alkermes Pharma Ireland Limited 156 patents | Foreign company or organization | Dublin, IE | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| John Devane | Athlone, IE | 16 | PVGPATDIS, file of 2026-04-10 | |
| Paul Stark | Dundrum, IE | 1 | PVGPATDIS, file of 2026-04-10 | |
| Niall Fanning | Dublin, IE | 1 | PVGPATDIS, file of 2026-04-10 | |
| Gurvinder Singh Rekhi | Suwanee, GA | 11 | PVGPATDIS, file of 2026-04-10 | |
| Scott Jenkins | Downingtown, PA | 3 | PVGPATDIS, file of 2026-04-10 | |
| Gary Liversidge | West Chester, PA | 2 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K9/5084 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P11/00 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2024-12-24 | Release of security interest Release of patent security agreement (first lien) | MORGAN STANLEY SENIOR FUNDING, INC. signed 2024-12-19 | ALKERMES, INC. WALTHAM, MA ALKERMES PHARMA IRELAND LIMITED DUBLIN 4 | 69771/548 | PASDL, file of 2026-10-15 |
| 2012-10-12 | Release of security interest Release by secured party (second lien) | MORGAN STANLEY SENIOR FUNDING, INC. signed 2012-09-24 | ALKERMES, INC. WALTHAM, MA ALKERMES PHARMA IRELAND LIMITED ATHLONE CO. WESTMEATH ALKERMES CONTROLLED THERAPEUTICS INC. WALTHAM, MA | 29116/379 | PASDL, file of 2026-10-15 |
| 2012-01-18 | Assignment Assignment of assignor's interest | ELAN PHARMA INTERNATIONAL LIMITED signed 2011-08-02 | EDT PHARMA HOLDINGS LIMITED DUBLIN 2 | 27552/1 | ECORSEXC, file of 2026-09-25 |
| 2012-01-18 | Name change Change of name | EDT PHARMA HOLDINGS LIMITED signed 2011-09-14 | ALKERMES PHARMA IRELAND LIMITED DUBLIN 2 | 27551/353 | ECORSEXC, file of 2026-09-25 |
| 2012-01-18 | Assignment Assignment of assignor's interest | ELAN CORPORATION, PLC signed 2006-12-31 | ELAN PHARMA INTERNATIONAL LIMITED COUNTY WESTMEATH | 27551/107 | ECORSEXC, file of 2026-09-25 |
| 2012-01-18 | Assignment Assignment of assignor's interest | DEVANE, JOHN G. signed 1999-10-29 STARK, PAUL signed 1999-10-29 | ELAN CORPORATION, PLC DUBLIN 2 | 27550/921 | ECORSEXC, file of 2026-09-25 |
| 2012-01-17 | Assignment Assignment of assignor's interest | FANNING, NIALL signed 2007-08-31 | ELAN PHARMA INTERNATIONAL LIMITED COUNTY WESTMEATH | 27543/320 | ECORSEXC, file of 2026-09-25 |
| 2012-01-17 | Assignment Assignment of assignor's interest | JENKINS, SCOTT signed 2007-12-18 REKHI, GURVINDER signed 2007-12-18 LIVERSIDGE, GARY signed 2008-01-02 | ELAN PHARMA INTERNATIONAL LIMITED COUNTY WESTMEATH | 27543/187 | ECORSEXC, file of 2026-09-25 |
| 2011-09-29 | Security interest Security interest Patent security agreement (second lien) | ALKERMES, INC. signed 2011-09-16 ALKERMES PHARMA IRELAND LIMITED signed 2011-09-16 ALKERMES CONTROLLED THERAPEUTICS INC. signed 2011-09-16 | MORGAN STANLEY SENIOR FUNDING, INC. NEW YORK, NY | 26994/245 | PASDL, file of 2026-10-15 |
| 2011-09-29 | Security interest Security interest Patent security agreement (first lien) | ALKERMES, INC. signed 2011-09-16 ALKERMES PHARMA IRELAND LIMITED signed 2011-09-16 ALKERMES CONTROLLED THERAPEUTICS INC. signed 2011-09-16 | MORGAN STANLEY SENIOR FUNDING, INC. NEW YORK, NY | 26994/186 | PASDL, file of 2026-10-15 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.